-
3 Two Hospital Networks and a Portable Molecular Testing Maker Stocks With a Strong Future Roadmap: Fortis Healthcare, Max Healthcare Institute and Molbio Diagnostics
- October 21, 2026
- Posted by: Chaitanya Auti
- Category: Best Stocks
No Comments
Hospital and Molecular Testing Stocks with a strong future roadmap: Fortis Healthcare, Max Healthcare Institute and Molbio Diagnostics. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.
-
Fortis Share Price: Sumeet Bagadia’s Buy Call, Target and Stop-Loss After the Fall
- October 21, 2026
- Posted by: Kunal Singla
- Category: News
Fortis share price at Rs 729 is below the Rs 745 stop-loss of Sumeet Bagadia’s buy call (target Rs 892). RSI, 52-week low, valuation and what to check before acting.
-
3 Hospital Stocks With a Strong Future Roadmap: Apollo Hospitals, Max Healthcare and Fortis Healthcare
- October 6, 2026
- Posted by: Neeraj Pandey
- Category: Best Stocks
Apollo Hospitals, Max Healthcare and Fortis Healthcare compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.
-
Buy, Sell Or Hold: Apollo Hospitals Enterprise, Max Healthcare Institute, Fortis Healthcare, Narayana Hrudayalaya, Global Health — Analyst Forecast
- September 28, 2026
- Posted by: Lakshit Sharma
- Category: Market
A look at 5 hospital sector stocks in India, Apollo Hospitals, Max Healthcare, Fortis Healthcare, Narayana Hrudayalaya and Global Health (Medanta), with a buy, hold or sell view on each.